American Brain Tumor Association
Events Care & Support Donate Tumor Info About Us Home Home
 

May 2010

 
null

Join the ABTA Chicago Marathon Team
Are you registered
for the 2010 Bank of America Chicago Marathon and interested in supporting ABTA's research and patient-family programs? Learn more.

ABTA May-June Events

May 15, 2010
Carmel, Ind.
6th Annual Head for a Cure

May 15, 2010
Logan Township, N.J.
7th Annual Matthew's Miles
 
May 22, 2010
Spokane, Wash.
2nd Annual Joggin for the Noggin
 
June 5, 2010
Royersford, Pa.
9th Annual Frank's Run
 
June 12-June 13, 2010
Conovor, Wis.
6th Annual Callie Rohr Canoe Race
 
June 19, 2010
Greendale, Wis.
Greendale Community Charity Walk
 
June 19, 2010
Watertown, N.Y.
3rd Annual Trainham Golf Outing
 
June 26, 2010
Seattle, Wash.
Seattle Rock 'n' Roll Half Marathon
 
June 26, 2010
Mansfield, Conn.
5th Annual Sharing Hope Walk the Walk-Talk the Talk

Twitter  FaceBook

 


Path to Progress 5K Countdown:
Still Time to Register, Run, Walk, Volunteer or Support
Never Give UpThe ABTA’s annual Path to Progress 5K Run/Walk is just days away, and we're more than halfway to our goal of raising $750,000 for brain tumor research and patient-family support programs. And it's not too late to participate! Register today for the Saturday, May 22nd, 5K Run/Walk at Chicago’s Soldier Field; or, volunteer to help at the event. If you cannot attend on May 22nd, please read our participant profiles and consider donating to an individual team. Questions? Contact the ABTA Events Team at pathtoprogress@abta.org or 800-886-1281.

May is Brain Tumor Awareness Month:
New ABTA Web Sites Help Patients and Families Connect
During Brain Tumor Awareness Month in May, the American Brain Tumor nullAssociation is launching two new interactive Web sites to help patients and families connect with others who are facing similar challenges, and to engage in efforts to find a cure. Connections allows you to communicate with others in the brain tumor community; create groups, blogs and a personal profile; share information and resources; and post photos of your brain tumor journey. Act Now! provides a growing brain tumor patient constituency with a forum for greater involvement in brain tumor advocacy efforts. You can also take the ABTA Brain Tumor Awareness Month Pledge and receive a comprehensive list of ways to spread brain tumor awareness in your community and beyond.

nullSpring Headlines Now Available
The new spring-summer issue of Headlines, ABTA's news magazine, includes articles on how integrative therapies may ease tumor symptoms and boost emotional well-being, how to start a support group, and ABTA's role as a patient advocate. You'll also meet a long-time brain tumor support group leader and mentor, and two friends who were brought together by ABTA and will soon reunite at the Path to Progress 5K Run/Walk on May 22, 2010. Read a copy online. To receive this and future issues of Headlines, please send a request to: info@abta.org.

ABTA Metastatic Brain Tumor Brochure Updatednull
Have you or someone you love been diagnosed with a metastatic brain tumor? Are you unsure what this means or what you should do from here? The expanded ABTA brochure Metastatic Brain Tumors can help you understand what a metastatic tumor is, what the possible treatment options are, and what questions you may want to ask your health care team.  For a free copy, please contact Patient Services at 800-886-2282, or send a request to info@abta.orgRead Metastatic Brain Tumors online.

2010 Medical Student Summer Fellows Announced
The American Brain Tumor Association is pleased to announce the 2010 ABTA Medical Student Summer Fellowship recipients. The goal of the program is to motivate talented medical students to pursue a career in neuro-oncology research by providing them with an introductory laboratory experience under the direction of an esteemed mentor. Each summer fellow receives a $3,000 grant. Read a full list of 2010 ABTA Summer Medical Student Fellows.

Updated Brain Tumor Facts & Statistics Available
Updated brain tumor facts and statistics, primarily based on the new 2010 report from the Central Brain Tumor Registry of the United States (CBTRUS), are now available on the ABTA Web site. Read ABTA’s 2010 Brain Tumor Facts and Statistics resource. Read the full 2010 CBTRUS report “Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006.
 

Interested in hosting an ABTA Event?
Call us at 1.800.886.1281

 
 

 
Back To Top

 
Patient Care and Support  
 

Young Adult Cancer Survivors Sought for Exercise Study
Are you a young adult cancer survivor living in Rhode Island or Massachusetts who would like to begin an exercise program? Previous research has shown that exercise can provide a number of benefits to cancer survivors, including improved mood and reduced fatigue. The Miriam Hospital in Providence, R.I. at the Centers for Behavioral and Preventive Medicine is testing a Web-based exercise program designed specifically for young adult cancer survivors. The Survivors Step into Motion study is funded by The National Cancer Institute. Learn more.

ASCO to Host "Answers to Cancer" Event on June 7
The American Society of Clinical Oncology (ASCO) will convene a panel, featuring some of the world's leading cancer experts, to discuss the importance of clinical trials, advances in survivorship and prevention, and other cancer research news, at the "Answers to Cancer" event on Monday, June 7, 2010, at the Sheraton Hotel and Towers in Chicago. Learn more.

Back To Top

 
tab research news  
 

Parvoviruses May Successfully Treat Brain Tumors
Researchers in Germany recently reported that parvoviruses – common viruses in animals and humans – injected into the brain tumors and blood streams of animal test subjects, resulted in complete tumor regression. As parvoviruses do not cause disease-related symptoms in humans, researchers believe they are suitable candidates for use in cancer, and particularly, brain tumor treatment. Read a news release on the research.

Childhood Cancer Deaths Decline, Incidence Rate Rises
A new review of more than three decades of childhood cancer deaths, incidence and survival found that an estimated 38,000 pediatric cancer deaths have been averted because of substantial advances in cancer drugs and treatment strategies, and continued return on past investments in cancer research. At the same time, however, childhood cancer incidence increased significantly with a form of leukemia rising most quickly. The incidence of childhood brain cancers remained stable. The researchers noted that innovative treatment strategies are needed to ensure continued progress against childhood cancers. Read a summary of the research from the American Society of Clinical Oncology. Read a free summary of the research in the Journal of Clinical Oncology. 

Brain Tumor News from AANS Annual Meeting
The American Association of Neurological Surgeons (AANS) recently hosted their annual meeting in Philadelphia. Brain tumor research findings presented at the meeting included:

Temozolomide Updates:
High-Dose Temozolomide Promising for Recurrent GBM
Clinical trial results recently published in the Journal of Clinical Oncology showed promising results in the continuous, dose-intensive use of temozolomide to treat recurring glioblastoma brain tumors. Read a free summary of the research.

Temozolomide Alone May Treat Oligodendroglioma
A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors showed promising results, adding to the growing body of research supporting chemotherapy as an acceptable alternative to radiotherapy. Oligodendroglioma brain tumors respond especially well to chemotherapy. Read a free summary of the research in the journal Neuro-Oncology

DNA Alteration Linked to Less Aggressive Gliomas
Researchers have identified DNA methylation (additional methyl affecting gene expression without damaging or altering the gene’s DNA sequence) of a specific set of genes linked to secondary glioblastomas, and specifically those that progress from lower-grade tumors. Patients with these glioblastomas tend to be younger, and tend to survive longer after diagnosis. The study authors hope the findings will lead to new treatments, particularly for glioblastoma patients with DNA methlylation. Read a news release on the research from the University of Texas M.D. Anderson Cancer Center. Read a free summary of the research in the journal Cancer Cell.

Back To Top

 
 

The American Brain Tumor Association funds brain tumor research and offers services to patients and family members worldwide. Help us continue these services by supporting ABTA programs. A donation can be made at http://www.abta.org/index.cfm?contentid=54.

This information is provided by the American Brain Tumor Association, 2720 River Road, Des Plaines, Illinois, 60018.

We can be reached by e-mail at info@abta.org, or by phone at 800-886-2282.

Update Email Preferences | Forward to a Friend | Unsubscribe
©2010 American Brain Tumor Association

 
This communication is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. The links set out on this communication are provided for your convenience only. The American Brain Tumor Association does not endorse the information contained on the linked Web sites or individual(s)/companies/institutions operating these websites.